Cited by 9,925Lymphoma Diagnosis and TreatmentBreast Cancer Treatment StudiesGene expression and cancer classification

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Alizadeh, Ash A., Eisen, Michael B., Davis, R. Eric, Ma, Chi, Lossos, Izidore S., Rosenwald, Andreas, Boldrick, Jennifer C., Sabet, Hajeer +23 more·2000·Nature

Abstract

Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of patients respond well to current therapy and have prolonged survival, whereas the remainder succumb to the disease. We proposed that this variability in natural history reflects unrecognized molecular heterogeneity in the tumours. Using DNA microarrays, we have conducted a systematic characterization of gene expression in B-cell malignancies. Here we show that there is diversity in gene expression among the tumours of DLBCL patients, apparently reflecting the variation in tumour proliferation rate, host response and differentiation state of the tumour. We identified two molecularly distinct forms of DLBCL which had gene expression patterns indicative of different stages of B-cell differentiation. One type expressed genes characteristic of germinal centre B cells ('germinal centre B-like DLBCL'); the second type expressed genes normally induced during in vitro activation of peripheral blood B cells ('activated B-like DLBCL'). Patients with germinal centre B-like DLBCL had a significantly better overall survival than those with activated B-like DLBCL. The molecular classification of tumours on the basis of gene expression can thus identify previously undetected and clinically significant subtypes of cancer.

Integrity signals

Registry

Crossref · 10.1038/35000501

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tumor samples have discrete transcriptome profile differences.

    “Thus, tumor samples have discrete transcriptome profile differences89,90”

    From Rare and common variants: twenty arguments (2012) · cites this paper as [89]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Levy, R., Wilson, W., Grever, M. R., Byrd, J. C., Botstein, D., Brown, P. O., & Staudt, L. M.
Affiliations
  • Stanford Medicine (US)
  • National Institutes of Health (US)
  • Center for Biologics Evaluation and Research (US)
  • Pediatrics and Genetics (US)
  • University of California, Berkeley (US)
  • University of Nebraska Medical Center (US)
  • Johns Hopkins University (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Staudt, Louis M.
Venue
Nature
Published
2000-02
Volume
403
Issue
6769
Pages
503-511
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2147246240
Cited by
9,925
References
49
Citations by year
2026: 142 · 2025: 211 · 2024: 207 · 2023: 322 · 2022: 300 · 2021: 335 · 2020: 340 · 2019: 341 · 2018: 304 · 2017: 320 · 2016: 352 · 2015: 366 · 2014: 382 · 2013: 379 · 2012: 416
FWCI
333.24
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • University of Nebraska Medical Center
  • School of Medicine, Stanford University
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Keywords
diffuse large B-cell lymphoma, gene expression profiling, B cell differentiation, host response, overall survival, non-Hodgkin lymphoma, tumor subtypes
MeSH terms
Adult, B-Lymphocytes, Humans, Phenotype, Tumor Cells, Cultured, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review